⌘K

Login Start Free

Home/Filings/4/0001304492-24-000026

4//SEC Filing

Gerbrandt Ryan 4

Accession 0001304492-24-000026

CIK 0001304492other

View on SEC.gov Company Profile

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 9:26 PM ET

Size

5.7 KB

Accession

0001304492-24-000026

Insider Transaction Report

Form 4

Period: 2024-02-28

Anterix Inc.ATEX

Chief Operating Officer

Transactions

Award
Stock Option (Right to Buy)
2024-02-28+60,000→ 60,000 total
Exercise: $37.42Exp: 2034-02-28→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]8,000 of the option shares vest and become exercisable on May 22, 2024; 32,000 additional option shares vest and become exercisable on May 22, 2025; and the remaining 20,000 unvested option shares vest and become exercisable on May 22, 2026.

Documents

1 file

4
wk-form4_1709346376.xmlPrimary
FORM 4

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1

filerCIK 0001821509

Filing Metadata

Form type: 4
Filed: Feb 29, 7:00 PM ET
Accepted: Mar 1, 9:26 PM ET
Size: 5.7 KB

View on SEC.gov